| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/09/2011 | EP2291080A1 Novel modulators of sphingosine phosphate receptors |
| 03/09/2011 | EP2291079A2 Formulations for cathepsin k inhibitors |
| 03/09/2011 | EP2291078A1 Oxazolobenzimidazole derivatives |
| 03/09/2011 | EP2291076A1 Angiotensin ii receptor antagonists |
| 03/09/2011 | EP2201006B1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 03/09/2011 | EP2188280B1 Imidazopyridinones |
| 03/09/2011 | EP2178512B1 Tableted compositions containing atazanavir |
| 03/09/2011 | EP2173349B1 Antitumour combinations containing a vegf inhibiting agent and irinotecan |
| 03/09/2011 | EP2144904B1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent |
| 03/09/2011 | EP2109615B1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 03/09/2011 | EP2079747B1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 03/09/2011 | EP2077998B1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/09/2011 | EP2049557B1 1- (-d-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as sglt inhibitors. |
| 03/09/2011 | EP2040566B1 Milk fever |
| 03/09/2011 | EP2034999B9 Dha esters and use thereof in the treatment and the prevention of cardiovascular diseases |
| 03/09/2011 | EP2032534B1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 03/09/2011 | EP2024375B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 03/09/2011 | EP1996194B1 Homotropanes with central nervous system activity |
| 03/09/2011 | EP1978970B1 Contraceptive |
| 03/09/2011 | EP1971338B1 Combination of zd6474 and pemetrexed |
| 03/09/2011 | EP1971332B1 Use of tiotropium salts in the treatment of moderate persistent asthma |
| 03/09/2011 | EP1954281B1 Cancer treatment method |
| 03/09/2011 | EP1917013B1 Use of azabicyclo hexane derivatives |
| 03/09/2011 | EP1912954B1 Novel cysteine protease inhibitors and their therapeutic applications |
| 03/09/2011 | EP1874770B1 Phenylacetamides suitable as protein kinase inhibitors |
| 03/09/2011 | EP1841735B1 Indoles useful in the treatment of inflammation |
| 03/09/2011 | EP1840129B1 Imidazothiazole derivative and method for producing same |
| 03/09/2011 | EP1838712B1 Pyrazolopyrimidine compounds as antitumor agents |
| 03/09/2011 | EP1836206B1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods |
| 03/09/2011 | EP1827602B1 Modulating retinal pigmented epithelium permeaion by inhibiting vegfr-1 |
| 03/09/2011 | EP1824845B1 1-arylpyrazoles and their use as pesticides |
| 03/09/2011 | EP1824475B1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 03/09/2011 | EP1756140B1 Selective separation or extraction of steroidal glycosides by supercritical fluid extraction using carbon dioxide |
| 03/09/2011 | EP1753765B1 Immuno inhibitory heterocyclic compounds |
| 03/09/2011 | EP1732920B1 Thiophene derivatives as chk 1 inhibitors |
| 03/09/2011 | EP1730151B1 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
| 03/09/2011 | EP1729597B1 The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and metabolic syndrome |
| 03/09/2011 | EP1723136B1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 03/09/2011 | EP1722759B1 Composition containing chitosan and a polyol-phosphate or a sugar-phosphate |
| 03/09/2011 | EP1709177B1 Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 03/09/2011 | EP1708685B1 Effervescent oral opiate dosage forms and methods of administering oxycodone |
| 03/09/2011 | EP1692116B1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 03/09/2011 | EP1641795B1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals |
| 03/09/2011 | EP1624845B1 4',4''-substituted 3alpha-(diphenylmethoxy)tropane analogs for the treatment of adhd |
| 03/09/2011 | EP1622925B1 Novel method and intermediates for the preparation of 19-nor-steroid compounds |
| 03/09/2011 | EP1622892B1 Indazoles having analgesic activity |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | EP1585730B1 Carboxamide derivatives and their use as factor xa inhibitors |
| 03/09/2011 | EP1562449B1 Composition for enhancing physical performance |
| 03/09/2011 | EP1559427B1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 03/09/2011 | EP1554289B1 A cefdinir intermediate |
| 03/09/2011 | EP1513812B1 Substituted indoles |
| 03/09/2011 | EP1513793B1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/09/2011 | EP1499297B1 Pharmaceutical formulation comprising atorvastatin calcium |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | EP1491206B9 Use of peptide derivatives for inducing cell differentiation |
| 03/09/2011 | EP1355910B1 Formulation of boronic acid compounds |
| 03/09/2011 | EP1276887B1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 03/09/2011 | EP1181320B1 Somatic transgene immunization and related methods |
| 03/09/2011 | EP1135178B1 Polymeric coatings with controlled delivery active agents |
| 03/09/2011 | EP1088098B1 Medicament for treating hiv-infected mammals |
| 03/09/2011 | CN1989962B Capsule comprising moguisteine |
| 03/09/2011 | CN1980891B Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS) |
| 03/09/2011 | CN1874757B Mucoactive agents for treating a pulmonary disease |
| 03/09/2011 | CN1651395B Borneol fatly acid ester derivative and preparation containing said derivative |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101984759A Modulation of factor 9 expression |
| 03/09/2011 | CN101984746A Foldable igniter |
| 03/09/2011 | CN101984036A Health vinegar and preparation method thereof |
| 03/09/2011 | CN101983964A Compound with antibacterial activity and antitumor activity and preparation method and applications thereof |
| 03/09/2011 | CN101983722A Composition for preventing and treating joint soft tissue injury and complications thereof |
| 03/09/2011 | CN101983721A Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
| 03/09/2011 | CN101983688A Drug for treating diabetes and preparation method thereof |
| 03/09/2011 | CN101983684A Drug for treating gastrosis and preparation method thereof |
| 03/09/2011 | CN101983653A Drug for treating lumbocrural pain and preparation method thereof |
| 03/09/2011 | CN101983634A Liquid for treating marginal blepharitis |
| 03/09/2011 | CN101983633A New application of polysaccharides from fructus rosae roxburghii for protection against ionizing radiation |
| 03/09/2011 | CN101983632A Compound Tilmicosin nanoemulsion antibacterial agent and preparation method thereof |
| 03/09/2011 | CN101983631A Composition for treating infection of pseudomonas aeruginosa in chicken and preparation method thereof |
| 03/09/2011 | CN101983630A Composition for treating salpingitis of birds and preparation method thereof |
| 03/09/2011 | CN101983629A Piperacillin sodium and sulbactam sodium drug composite microsphere injection |
| 03/09/2011 | CN101983628A Mezlocillin sodium and sulbactam sodium drug composite microsphere injection |
| 03/09/2011 | CN101983627A Application of epigallocatechin gallate (EGCG) in intervention of fetal alcohol-related diseases |
| 03/09/2011 | CN101618061B Medicine for treating chronic pharyngitis and preparation method thereof |
| 03/09/2011 | CN101513409B Pharmaceutical composition of cephalexin |
| 03/09/2011 | CN101497614B 1,2,3,5,11,11a- hexahydro-3,3-dimethyl-1-oxo-6H-glyoxaline [3', 4': 1,2] pyridine [3,4-b] diindyl-2-substituted methyl acetate, as well as preparation and application thereof |
| 03/09/2011 | CN101444510B Pharmaceutical preparation containing voriconazole and preparation method thereof |
| 03/09/2011 | CN101326167B Pyridiazinone derivatives for tumour treatment |
| 03/09/2011 | CN101326163B Prolinamide derivatives as sodium channel modulators |
| 03/09/2011 | CN101311166B Tyrosine kinase restraining agent, preparation method thereof and use |
| 03/09/2011 | CN101309677B Cleaner for precaution against of cow's hoof, manufacturing method thereof, and using method thereof |
| 03/09/2011 | CN101306082B Houkangsan quality control method |
| 03/09/2011 | CN101284009B Cefoperazone sodium and sulbactam sodium combination and preparation method thereof |
| 03/09/2011 | CN101274049B Medicament for curing multiple traumas |
| 03/09/2011 | CN101263130B 2-苯胺-4-芳基取代的噻唑衍生物 2-anilino-4-aryl-substituted thiazole derivative |
| 03/09/2011 | CN101234100B Application of naphthoquinone compounds |
| 03/09/2011 | CN101230033B New azabicycloalkane derivatives, preparing method and medicament combination containing the same |
| 03/09/2011 | CN101180043B Versatile high load concentrate compositions for control of ecto-parasites |
| 03/09/2011 | CN101133057B Triazolophthalazines |
| 03/08/2011 | US7902441 Group of recessive oncogenes, Fus1, 101F6, Gene 21 (NPRL2), Gene 26 (CACNA2D2), Luca 1 (HYAL1), Luca 2 (HYAL2), PL6 ,123F2 (RaSSFI), SEM A3 and Beta* (BLU), defined by homozygous deletion in lung cancer, have been located, isolated at 3p21.3 |